Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.
Hum Vaccin Immunother
; : 2099210, 2022 Jul 26.
Article
in English
| MEDLINE | ID: covidwho-1956541
ABSTRACT
This study was conducted to ascertain whether people in China would be willing to pay for an inactivated COVID-19 vaccine booster dose. An online survey estimating participants' willingness to pay (WTP) for a booster dose of COVID-19 vaccine was conducted in Taizhou, China. The participants received ane-mail or e-poster on WeChat. A total of 1576 subjects participated the survey. A total of 66.4% (1046/1576) of the respondents were willing to pay for a booster dose of COVID-19 vaccine for themselves. Using binary logistic regression analysis, the following factors were significantly related to a WTP for a booster dose of COVID-19 vaccine 1) confidence in the safety of the COVID-19 vaccines (high vs. low, OR 4.30, 95%CI 1.61-11.43), 2) confidence in the preventive effectiveness of the COVID-19 vaccines against SARS-CoV-2 virus (moderate vs. little, OR 1.76, 95%CI 1.30-2.38; great vs. little, OR 2.244, 95%CI 1.62-3.12), and 3) COVID-19 vaccine hesitancy (unhesitant vs. very unhesitant, OR 0.67, 95%CI 0.45-1.02; hesitant vs. very unhesitant, OR 0.29, 95%CI 0.19-0.44; very hesitant vs. very unhesitant, OR 0.09, 95%CI 0.03-0.27). This study revealed that a moderate proportion of participants responded that they would be willing to pay for a booster dose of COVID-19 vaccine. These findings suggest the importance of a detailed assessment and a health education plan that better understands the population's risk perception as well as the potential health risks in China.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Hum Vaccin Immunother
Year:
2022
Document Type:
Article
Affiliation country:
21645515.2022.2099210
Similar
MEDLINE
...
LILACS
LIS